Xtant Medical (XTNT) entered into a licensing agreement with Sites Medical for use of OsteoSync™ Ti porous titanium scaffold technology.
OsteoSync Ti is a highly-porous titanium scaffold. Preclinical testing has demonstrated bone attachment strength at nearly 2x that of titanium plasma spray and ~7x that of PEEK material at 5-week follow-up.
XTNT estimates that the total addressable U.S. market for its products that can use OsteoSync Ti is US $2.5BB, with a 5-year CAGR approaching 4.75%.
First products arising from this partnership will be showcased in 4Q17 at NASS. The initiative supports XTNT’s intention to fill portfolio gaps via licensing agreements with strategic partners.
Sources: Xtant Medical, Inc.; sitesmedical.com; ORTHOWORLD Inc.
Xtant Medical (XTNT) entered into a licensing agreement with Sites Medical for use of OsteoSync™ Ti porous titanium scaffold technology.
OsteoSync Ti is a highly-porous titanium scaffold. Preclinical testing has demonstrated bone attachment strength at nearly 2x that of titanium plasma spray and ~7x that of PEEK material at 5-week...
Xtant Medical (XTNT) entered into a licensing agreement with Sites Medical for use of OsteoSync™ Ti porous titanium scaffold technology.
OsteoSync Ti is a highly-porous titanium scaffold. Preclinical testing has demonstrated bone attachment strength at nearly 2x that of titanium plasma spray and ~7x that of PEEK material at 5-week follow-up.
XTNT estimates that the total addressable U.S. market for its products that can use OsteoSync Ti is US $2.5BB, with a 5-year CAGR approaching 4.75%.
First products arising from this partnership will be showcased in 4Q17 at NASS. The initiative supports XTNT’s intention to fill portfolio gaps via licensing agreements with strategic partners.
Sources: Xtant Medical, Inc.; sitesmedical.com; ORTHOWORLD Inc.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.